Inari Medical downgraded to Neutral from Buy at BTIG

BTIG downgraded Inari Medical (NARI) to Neutral from Buy without a price target after Stryker (SYK) entered a definitive agreement to acquire the company for $80 per share in cash. With Inari now trading at a 1% discount to its takeout price, BTIG is downgrading the shares, the analyst tells investors in a research note.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue